Protagonist Therapeutics, Inc. [NASDAQ: PTGX] shares went lower by -37.96% from its previous closing of $8.85, now trading at the price of $5.49, also adding -3.36 points. Is PTGX stock a buy or should you stay away?
The stock had a rather active trading session with the latest closing, by far recording 1.07 million contracts. Compared to the average trading volume of PTGX shares, the company saw a far better performance. Moreover, the stock has a 26.02M float and a -26.79% run over in the last seven days. PTGX share price has been hovering between $16.67 and $6.18 lately, and is definitely worthy of attention.
Protagonist Therapeutics, Inc. [NASDAQ:PTGX]: Analyst Rating and Earnings
Its stock price has been found in the range of 6.18 to 16.67. This is compared to its latest closing price of $8.85.
Stay on the lookout for the next publication of this organization’s financial results for the quarter, which will be made public on Wed 6 Nov (27 days ago).
Fundamental Analysis of Protagonist Therapeutics, Inc. [PTGX]
Now let’s turn to look at profitability: with a current Operating Margin for Protagonist Therapeutics, Inc. [PTGX] sitting at -136.68.
This company’s Return on Total Capital is -36.26, and its Return on Invested Capital has reached -36.90%. Its Return on Equity is -33.39, and its Return on Assets is -25.67. These metrics suggest that this Protagonist Therapeutics, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business
What about valuation? This company’s Enterprise Value to EBITDA is -2.39. The Enterprise Value to Sales for this firm is now -739.06. Protagonist Therapeutics, Inc. [PTGX] has a Price to Book Ratio of 1.39.
Shifting the focus to workforce efficiency, Protagonist Therapeutics, Inc. [PTGX] earns $483,203 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.36 and its Total Asset Turnover is 0.20. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 5.26 and its Current Ratio is 5.26. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Protagonist Therapeutics, Inc. [PTGX] has 27.21M shares outstanding, amounting to a total market cap of $240.81M. Its stock price has been found in the range of 6.18 to 16.67. At its current price, it has moved down by -67.06% from its 52-week high, and it has moved down -11.16% from its 52-week low.
This stock’s Relative Strength Index (RSI) is at 23.24. This stock, according to these metrics, is currently Oversold.
Conclusion: Is Protagonist Therapeutics, Inc. [PTGX] a Reliable Buy?
Protagonist Therapeutics, Inc. [PTGX] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.